SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001144204-18-016444
Filing Date
2018-03-22
Accepted
2018-03-22 16:47:26
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tv489136_s3.htm S-3 264981
2 EXHIBIT 5.1 tv489136_ex5-1.htm EX-5.1 13429
3 EXHIBIT 23.1 tv489136_ex23-1.htm EX-23.1 2724
4 EXHIBIT 23.2 tv489136_ex23-2.htm EX-23.2 2244
5 GRAPHIC image_001.jpg GRAPHIC 9174
6 GRAPHIC image_002.jpg GRAPHIC 10724
  Complete submission text file 0001144204-18-016444.txt   312126
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-223857 | Film No.: 18707450
SIC: 8731 Services-Commercial Physical & Biological Research